Please login to the form below
Healthcare Glossary
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
European Medicines Agency
The European Medicines Agency (EMA) is a European agency for the evaluation of medicinal products. From 1995 to 2004, the European Medicines Agency was known as European Agency for the Evaluation of Medicinal Products.
See also:
Food And Drug
Administration
External
links:
Food and Drug Administration
(FDA)
European Medicines Agency (EMA)
Related terms
Investigational new drug (IND), Bias, Prior approval, Blind (clinical trial terms), Toxicity, Persistence, Cost-minimisation analysis (CMA), Adverse reaction, Indication, Research and development (R&D), Drug-drug interaction, Drug tariff, Committee for Medicinal Products for Human Use (CHMP), Prescription only medicine (POM), Experimental drug,
Subscribe to our email news alerts
Featured jobs
- Country Manager, Healthcare Communications Agency, Germany
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- bluebird bio reveals plans to launch two gene therapies
- AstraZeneca and MSD’s breast cancer drug Lynparza receives EC approval
- Eli Lilly to make bebtelovimab commercially available to US states from August
- AbbVie and Sosei Heptares collaborate in new agreement worth up to $1.2bn
- ONS records a continued fall in UK COVID-19 infections
- Regeneron terminates four clinical trials of its COVID-19 antibody cocktail REGEN-COV
- My body. My choice. Are we all talking about the same thing?
- BeiGene announces positive phase 3 trial results for liver cancer treatment
- Sanofi halts recruitment for trials assessing MS treatment
- Merck and Cerevance to research novel targets in Alzheimer’s disease
- Michael J Fox Foundation awards Koneksa second research grant
- FDA approves Bot Image’s AI software for the detection and diagnosis of prostate cancer
- GSK/Merck KGgA cancer drug fails in third trial
- GSK’s ViiV and Medicines Patent Pool agree deal for HIV prevention
- Avastin wins EU approval for advanced renal cancer
- College of Medicine launches Beyond Pills campaign to tackle overprescribing in UK health system
- Regeneron terminates four clinical trials of its COVID-19 antibody cocktail REGEN-COV
- Roche shares new positive Ocrevus data for MS patients
PMHub
Oxford PharmaGenesis
Oxford PharmaGenesis is an independently owned HealthScience communications consultancy, providing services to the healthcare industry, professional societies and patient groups....
